Adicet Income Statement Research

ACET Stock

USD 2.00 0.05 2.56%

Most accounts from Adicet Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Adicet Bio Valuation and Adicet Bio Correlation analysis.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 230.1 M in 2024, whereas Total Revenue is likely to drop 0.00 in 2024.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 230.1 M in 2024, whereas Total Revenue is likely to drop 0.00 in 2024.

	2023	2024 (projected)
Total Operating Expenses	126.5M	69.4M
Cost Of Revenue	6.1M	5.8M

Total Operating Expenses Cost Of Revenue

Adicet Bio income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		0.91	0.81	0.74	0.79	0.77	0.55	0.55	-0.3	0.6	0.72	0.33	0.51	-0.31	0.45	0.81	-0.33	-0.06	-0.06	0.14	-0.07	0.06
Interest Expense	0.91		0.82	0.78	0.86	0.76	0.7	0.7	-0.49	0.73	0.75	0.17	0.67	-0.13	0.62	0.84	-0.45	-0.33	-0.33	0.38	-0.34	0.28
Selling General Administrative	0.81	0.82		0.95	0.94	0.98	0.72	0.72	-0.49	0.75	0.94	0.24	0.69	-0.19	0.63	0.92	-0.41	-0.24	-0.24	0.31	-0.29	0.18
Total Revenue	0.74	0.78	0.95		0.97	0.97	0.88	0.88	-0.73	0.89	1.0	-0.01	0.86	0.07	0.82	0.96	-0.63	-0.47	-0.47	0.54	-0.47	0.4
Gross Profit	0.79	0.86	0.94	0.97		0.92	0.89	0.89	-0.71	0.91	0.95	0.05	0.87	0.08	0.83	0.98	-0.61	-0.5	-0.5	0.57	-0.5	0.45
Other Operating Expenses	0.77	0.76	0.98	0.97	0.92		0.74	0.74	-0.55	0.76	0.97	0.12	0.71	-0.15	0.66	0.91	-0.48	-0.25	-0.25	0.33	-0.32	0.16
Operating Income	0.55	0.7	0.72	0.88	0.89	0.74		1.0	-0.95	1.0	0.87	-0.36	1.0	0.46	0.99	0.88	-0.86	-0.8	-0.8	0.86	-0.77	0.7
Ebit	0.55	0.7	0.72	0.88	0.89	0.74	1.0		-0.95	1.0	0.87	-0.37	1.0	0.46	0.99	0.87	-0.86	-0.79	-0.79	0.86	-0.77	0.7
Research Development	-0.3	-0.49	-0.49	-0.73	-0.71	-0.55	-0.95	-0.95		-0.93	-0.72	0.57	-0.96	-0.65	-0.98	-0.7	0.91	0.9	0.9	-0.94	0.84	-0.81
Ebitda	0.6	0.73	0.75	0.89	0.91	0.76	1.0	1.0	-0.93		0.88	-0.33	0.99	0.42	0.98	0.9	-0.85	-0.77	-0.77	0.83	-0.75	0.68
Cost Of Revenue	0.72	0.75	0.94	1.0	0.95	0.97	0.87	0.87	-0.72	0.88		-0.02	0.84	0.06	0.81	0.94	-0.63	-0.45	-0.45	0.53	-0.46	0.39
Total Operating Expenses	0.33	0.17	0.24	-0.01	0.05	0.12	-0.36	-0.37	0.57	-0.33	-0.02		-0.39	-0.67	-0.45	0.02	0.62	0.57	0.57	-0.62	0.73	-0.34
Income Before Tax	0.51	0.67	0.69	0.86	0.87	0.71	1.0	1.0	-0.96	0.99	0.84	-0.39		0.51	1.0	0.85	-0.86	-0.82	-0.82	0.88	-0.79	0.73
Total Other Income Expense Net	-0.31	-0.13	-0.19	0.07	0.08	-0.15	0.46	0.46	-0.65	0.42	0.06	-0.67	0.51		0.57	0.04	-0.51	-0.79	-0.79	0.8	-0.72	0.8
Net Income	0.45	0.62	0.63	0.82	0.83	0.66	0.99	0.99	-0.98	0.98	0.81	-0.45	1.0	0.57		0.8	-0.88	-0.86	-0.86	0.92	-0.82	0.77
Income Tax Expense	0.81	0.84	0.92	0.96	0.98	0.91	0.88	0.87	-0.7	0.9	0.94	0.02	0.85	0.04	0.8		-0.61	-0.47	-0.47	0.53	-0.47	0.39
Tax Provision	-0.33	-0.45	-0.41	-0.63	-0.61	-0.48	-0.86	-0.86	0.91	-0.85	-0.63	0.62	-0.86	-0.51	-0.88	-0.61		0.73	0.73	-0.85	0.74	-0.62
Net Interest Income	-0.06	-0.33	-0.24	-0.47	-0.5	-0.25	-0.8	-0.79	0.9	-0.77	-0.45	0.57	-0.82	-0.79	-0.86	-0.47	0.73		1.0	-0.97	0.89	-0.92
Interest Income	-0.06	-0.33	-0.24	-0.47	-0.5	-0.25	-0.8	-0.79	0.9	-0.77	-0.45	0.57	-0.82	-0.79	-0.86	-0.47	0.73	1.0		-0.97	0.89	-0.92
Net Income From Continuing Ops	0.14	0.38	0.31	0.54	0.57	0.33	0.86	0.86	-0.94	0.83	0.53	-0.62	0.88	0.8	0.92	0.53	-0.85	-0.97	-0.97		-0.91	0.89
Reconciled Depreciation	-0.07	-0.34	-0.29	-0.47	-0.5	-0.32	-0.77	-0.77	0.84	-0.75	-0.46	0.73	-0.79	-0.72	-0.82	-0.47	0.74	0.89	0.89	-0.91		-0.68
Selling And Marketing Expenses	0.06	0.28	0.18	0.4	0.45	0.16	0.7	0.7	-0.81	0.68	0.39	-0.34	0.73	0.8	0.77	0.39	-0.62	-0.92	-0.92	0.89	-0.68

Click cells to compare fundamentals

Adicet Bio Account Relationship Matchups

Pair Trading with Adicet Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adicet Stock

0.64	DH	Definitive Healthcare Financial Report 2nd of May 2024	Pair Corr
0.77	GH	Guardant Health Upward Rally	Pair Corr
0.78	FIGS	Figs Inc Financial Report 2nd of May 2024	Pair Corr

Moving against Adicet Stock

0.79	WGS	GeneDx Holdings Corp Earnings Call This Week	Pair Corr
0.65	RCM	R1 RCM Inc Financial Report 2nd of May 2024	Pair Corr
0.6	GCTK	GlucoTrack	Pair Corr
0.53	FORA	Forian Inc Financial Report 10th of May 2024	Pair Corr
0.42	HQY	HealthEquity Financial Report 3rd of June 2024	Pair Corr

The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.

The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Adicet Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Adicet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Adicet Bio Stock. Highlighted below are key reports to facilitate an investment decision about Adicet Bio Stock:

How To Invest In Adicet

Details

Is Adicet Stock a good investment?

Details

What is Adicet Bio's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Adicet Bio Valuation and Adicet Bio Correlation analysis.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Adicet Stock analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.

	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.31)

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.31)

Return On Equity

(0.62)

The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adicet Income Statement Research

Adicet Bio income statement Correlations

Adicet Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with Adicet Bio

Moving together with Adicet Stock

Moving against Adicet Stock

Complementary Tools for Adicet Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Total Revenue
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit

Net Income	- 0.98	Research Development
Net Income From Continuing Ops	- 0.97	Interest Income
Net Income From Continuing Ops	- 0.97	Net Interest Income
Income Before Tax	- 0.96	Research Development
Research Development	- 0.95	Ebit
Research Development	- 0.95	Operating Income